Huajian Medical, which has deployed RWA digital assets, saw its market value surge by HK$14 billion in two months.

Huajian Medical (now renamed "Huajian Digital Industry Group") recently announced that the ETHK Building in Nanjing has been officially completed and put into use.

Positioned as the world's first demonstration base dedicated to the research and development of digital technologies for real-world assets (RWA), the building aims to promote the deep integration of asset digitization and blockchain technology in fields such as healthcare, and to build an innovative ecosystem that integrates technology research and development, transformation of results, and industrial applications.

Since July of this year, Huajian Medical has made frequent strategic moves, including completing its acquisition of a controlling stake in Guofu Quantum and taking the lead in establishing a special fund focused on the tokenization of innovative drug intellectual property rights.

This series of layouts has significantly boosted market confidence, and the company's market value has soared from HK$3 billion to HK$17 billion, demonstrating the capital market's high recognition of its digital transformation strategy.

With the expansion of its business focus to the digital field, the company officially changed its name to "Huajian Digital Industry Group", marking its entry into a new stage of development driven by the dual wheels of "medical and digital technology".

In addition, the Group has reached a strategic partnership with Renhe Pharmaceutical. The two parties will jointly establish a Real World Asset (RWA) exchange for OTC drugs in the United States.

This partnership aims to promote the tokenization and on-chain circulation of medical assets, thereby enhancing industry transparency, transaction efficiency, and asset liquidity.

This series of initiatives not only demonstrates Huajian's clear path to transform from a traditional medical enterprise to a digital industrial group, but also heralds its strategic determination to seize first-mover advantage in the global wave of medical asset digitization.